期刊文献+

泊沙康唑(API)生产化工艺研究及杂质谱分析 被引量:3

Study on Production Process and Impurities Analysis of Posaconazole( API)
下载PDF
导出
摘要 泊沙康唑作为治疗抗真菌感染,现有文献及合成工艺优化,虽然有的文献报道可以工业化生产,但是没有作为原料药(API)参照QBD理念,充分考虑作为API的要求去设计工艺,也没有杂质谱的分析。泊沙康唑(posaconazole)是2006年9月15日由美国FDA批准的一种广谱三唑类抗真菌药,用于难治性疾病或其他药物耐药所引起的真菌感染(如曲霉菌病、结核菌病和镰刀菌病等),该药由美国Scher. ing-Plough公司研制上市,商品名为Noxafil。本文主要介绍作为原料药,而非化工品适合于工业化生产的工艺研究,及其作为原料药在药物申报阶段,从起始原料开始至API的杂质谱的分析与控制。 As a therapeutic antifungal infection,posaconazole is optimized in the existing literature and synthetic process.Although some literature reports it can be industrialized,it does not refer to the QBD concept as a drug substance(API),and no fully considers the design process as an API requirement.There is no analysis of the impurity spectrum.Posaconazole is a broad-spectrum triazole antifungal drug approved by the US FDA on September 15,2006 for fungal infections caused by refractory diseases or other drug resistance.(such as Aspergillosis,Tuberculosis and Fusarium),the drug is made by Scher.ing-Plough company is on the market,the trade name is Noxafil.This paper mainly introduces the process research as a raw material drug,not a chemical product suitable for industrial production,and as a raw material drug in the drug declaration stage,from the starting material to the analysis and control of the impurity spectrum of the API.
作者 郭彦飞 蓸卫 包玉盛 刘婷婷 Guo Yanfei;Cao Wei;Bao Yusheng;Liu Tingting(Nanjing Heron Pharmaceutical Science and Technology Co.,Ltd.,Nanjing 211100,China)
出处 《山东化工》 CAS 2018年第23期47-51,55,共6页 Shandong Chemical Industry
关键词 泊沙康唑 治疗真菌感染 合成工艺 杂质谱分析 Posaconazole treatment of fungal infection synthesis process research impurity spectrum analysis
  • 相关文献

参考文献2

二级参考文献19

  • 1Vehreschild J J, Ruping MJ, Wisplinghoff H, et al. Clinical effectiveness of posaconazole prophylaxis in patients with a- cute myelogenous leukaemia (AMID : a 6 year experience of the Cologne AML cohort [J]. J Antimicrob Chemother, 2010,65(7) : 1466-1471. 被引量:1
  • 2Sanchez-Ortega I, Patino B, Arnan M, et al. Clinical efficacy and safety of primary antifungal prophylaxis with posacon- azole vs itraconazole in allogeneic blood and marrow trans- piantation[J]. Bone Marrow Transplant, 2011,46(5) : 733- 739. 被引量:1
  • 3Winston DJ, Bartoni K, Territo MC, et al. Efficacy, safety, and breakthrough infections associated with standard long- term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients[J]. Biol Blood Marrow Trans- plant, 2011,17(4) :507-515. 被引量:1
  • 4Zoller E, Valente C, Baker K, et al. Development, clinical u- tility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections[J]. Drug Des DeveI T her, 2010,4:299- 311. 被引量:1
  • 5Rogers TR, Slavin MA, Donnelly JP. Antifungal prophylaxis during treatment for haematological malignancies: are we there yet[J], Br J Haematol, 2011,153(6):681-697. 被引量:1
  • 6Walsh TJ, Raad I, Patterson TF, et aI. Treatment of inva- sire aspergillosis with posaconazole in patients who are refrae tory to or intolerant of conventional therapy: an externally controlled trial[J]. Clin Infect Dis, 2007,44(1):2- 12. 被引量:1
  • 7Raad II, Hanna HA, Boktour M, et al. Novel antifungal a-gents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphoteriein B alone or in combination with caspofungin [J]. Leukemia, 2008,22 (3) 496-503. 被引量:1
  • 8Morris MI. Posaconazole: a new oral antifungal agent with an expanded spectrum of activity[J]. Am J Health Syst Pharm, 2009,66(3) :225-236. 被引量:1
  • 9Greenberg RN, Mullane K, van Burik JA, et al. Posacon- azole as salvage therapy for zygomyeosis[J]. Antimicrob A gents Chemother, 2006,50 ( 1 ) : 126-133. 被引量:1
  • 10van Burik JA, Hare RS, Solomon HF, et al. Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases[J]. Clin Infect Dis, 2006,42(7) : e61 -65. 被引量:1

共引文献8

同被引文献29

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部